LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma - Wikidata - awgldk - TriplyDB

LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma

LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma

http://www.wikidata.org/entity/Q34306833

about

TGF-β1 expression in chromophobe renal cell carcinoma and renal oncocytoma.Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.Effect of Xianziyizhen Recipe Capsule on PGI2-PPARδ Signaling Pathway in Embryo Implantation Dysfunction Mice.

P2860

Q31157692-09E78D52-8025-4EBD-B395-13C446E8FB28 Q36019521-F803CD93-900C-424E-8308-F42B9AC83716 Q38763962-8556F104-8CD9-4363-AF43-5D0F41EE5F33 Q45839919-C6AF7CC6-4AA4-43E3-B7B5-B6571555CADA Q53594852-7763FEC0-2D07-498B-B643-CC558F273F6D Q53620443-768E7CDD-4345-4DC9-9F60-884291579C25

P2860

LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma

http://www.wikidata.org/entity/Q34306833

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@ast

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@en

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@nl

type

label

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@ast

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@en

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@nl

prefLabel

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@ast

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@en

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@nl

P1433

Q34306833-46EC1CA6-582C-4EF0-8D7A-CD30BF3ACB36

P1476

Q34306833-78D7F6C8-D04A-42E9-BB13-E85035CD47F4

P2093

Q34306833-7AFBEA4B-3F0E-46C5-AAB3-006FF868A8D1

Q34306833-B0CDBD77-AE5C-4DE6-AA09-15A8DA5A5FE5

Q34306833-E0573E7F-A9EE-4BCD-BA19-F622F57C02DD

Q34306833-E58071EE-0CA3-43AE-BF97-283447D71D32

Q34306833-EB9D6EA8-BCCA-4323-9DDE-F06E2AC3716B

P2860

Q34306833-0D78FB79-98FA-434B-960D-1492A8C0B8BE

Q34306833-2DFC849F-1459-4BB8-9C8F-99B7B5C18357

Q34306833-36A4FB13-A38A-4F40-967B-2B027F2EF353

Q34306833-430FECD4-BF44-4F9B-BA88-2FED970A8DA2

Q34306833-4EF79483-418F-4D66-8472-74E93FAE2650

Q34306833-50AF2F75-50D5-402A-B327-81203DC2D5C8

Q34306833-5289BC87-6E6C-483A-B52D-3879CBB52E95

Q34306833-5BF9C8C1-12BF-4DD3-9A15-82AD20BF8A4B

Q34306833-65696490-9811-4619-B092-8E5B86280594

Q34306833-66C5ACE4-7A6B-4F2F-9BEF-A6CB06356F9D

P304

Q34306833-CFCFB293-5A1A-4D0E-80D3-DE8DF59E87C8

P31

Q34306833-3A9F0E4D-8C96-4056-BE48-E872FF9163F5

P356

Q34306833-50102A27-D963-457A-A56B-5FA73DB63A2E

P433

Q34306833-8FD272AE-A820-4FCF-8EFF-55DCB393DB2A

P478

Q34306833-3369FD68-0D77-4FFD-985B-35921DDF8C8E

P577

Q34306833-B8376796-606F-4A5B-B94E-621B4D27A476

P698

Q34306833-CA15754F-A52E-4FB1-B612-82B4A299ADA3

P921

Q34306833-892A8D9F-6251-4F6A-B168-AAE737FDE59A

Q34306833-A9EE9842-3C4E-45B7-8761-ACCD84AADAFC

P932

Q34306833-DA6B6DB4-8DF2-44DA-BDE9-698C3290F607

P356

J.YEXMP.2012.05.008

P1433

Experimental and Molecular Pathology

P1476

LMP2, a novel immunohistochemi ...... romophobe renal cell carcinoma

@en

P2093

Alcides Chaux

http://www.w3.org/2001/XMLSchema#string

Gang Zheng

http://www.w3.org/2001/XMLSchema#string

George Netto

http://www.w3.org/2001/XMLSchema#string

Patrizio Caturegli

http://www.w3.org/2001/XMLSchema#string

Rajni Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports

Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity

Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.

Review of renal oncocytoma with focus on clinical and pathobiological aspects.

Renal oncocytoma: a clinicopathologic study of 70 cases.

Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.

Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid

Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and function

Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

The 26 S proteasome: from basic mechanisms to drug targeting.

P304

29-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YEXMP.2012.05.008

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22705098

http://www.w3.org/2001/XMLSchema#string

P921

eosinophilic variant of chromophobe renal cell carcinoma

immunohistochemistry

P932

3459143

http://www.w3.org/2001/XMLSchema#string